Researchers concluded, “The evidence is sufficient to establish a potentially beneficial association between recreational marijuana legislation and prescription opioid patterns.”
The agency had previously opined that regulating hemp-derived CBD products as dietary supplements could potentially discourage the use and development of CBD prescription drugs.
“Our research found CBC to enhance the cytotoxic effect of CBD, establishing additional support for the phenomenon of the entourage effect,” investigators concluded.